| 1 |
Kim HH, Han SU, Kim MC, et al. Effect of laparoscopic distal gastrectomy vs open distal gastrectomy on long-term survival among patients with stage i gastric cancer: the KLASS-01 randomized clinical trial[J]. JAMA Oncol，2019，5(4):506-513.
|
| 2 |
Katai H, Mizusawa J, Katayama H, et al. Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial[J]. Lancet Gastroenterol Hepatol，2020，5(2):142-151.
|
| 3 |
Katai H, Mizusawa J, Katayama H, et al. Single-arm confirmatory trial of laparoscopy-assisted total or proximal gastrectomy with nodal dissection for clinical stage Ⅰ gastric cancer: japan clinical oncology group study JCOG1401[J]. Gastric Cance，2019, 22 (5):999-1008.
|
| 4 |
Hyung WJ, Yang HK, Han SU，et al. A feasibility study of laparoscopic total gastrectomy for clinical stage I gastric cancer: a prospective multi-center phase Ⅱ clinical trial, KLASS 03[J]. Gastric Cancer，2019，22 (1):214-222.
|
| 5 |
Okabe H, Tsunoda S, Obama K, et al. Feasibility of laparoscopic radical gastrectomy for gastric cancer of clinical stage Ⅱ or higher: early outcomes in a phase Ⅱ study (KUGC04) [J]. Ann Surg Oncol，2016，23 (4):516-523.
|
| 6 |
Lee HJ, Hyung WJ, Yang HK, et al. Short-term outcomes of a multicenter randomized controlled trial comparing laparoscopic distal gastrectomy with D2 lymphadenectomy to open distal gastrectomy for locally advanced gastric cancer (KLASS-02-RCT) [J]. Ann Surg，2019，270(6):983-991.
|
| 7 |
Yu J, Huang C, Sun Y, et al. Effect of laparoscopic vs open distal gastrectomy on 3-year disease-free survival in patients with locally advanced gastric cancer: the CLASS-01 randomized clinical trial[J]. JAMA，2019，321(20):1983-1992.
|
| 8 |
Kinoshita T, Uyama I, Terashima M, et al. Long-term outcomes of laparoscopic versus open surgery for clinical stage Ⅱ/Ⅲ gastric cancer: a multicenter cohort study in japan (LOC-A Study) [J]. Ann Surg，2019，69(5):887-894.
|
| 9 |
Sugita S, Kinoshita T, Kuwata T, et al. Long-term oncological outcomes of laparoscopic versus open transhiatal resection for patients with Siewert type Ⅱ adenocarcinoma of the esophagogastric junction[J]. Surg Endosc，2020. DOI：
10.1007/s00464-020-07406-w.
|
| 10 |
Lee CM, Lee S, Lee D, et al. How does combined resection affect the clinical outcomes after laparoscopic surgery for serosa-positive gastric cancer: a retrospective cohort study to investigate the short-term outcomes of laparoscopic combined resection in patients with T4b gastric cancer[J]. Front Oncol，2019，9:1564. DOI：
10.3389/fonc.2019.01564.
|
| 11 |
Zhou SN, Yang B, Tan JN, et al. Feasibility, safety and long-term efficacy of laparoscopic total gastrectomy combined with distal pancreaticosplenectomy for T4b gastric cancer [J]. Zhonghua wei chang wai ke za zhi，2020, 23(2):163-169.
|
| 12 |
Hellman S, Weichselbaum RR. Oligometastases [J]. Journal of clinical oncology，1995, 13(1):8-10.
|
| 13 |
Min SH, Won Y, Lee K, et al. Laparoscopic gastrectomy and metastasectomy for stage Ⅳ gastric cancer [J]. Surgical endoscopy，2020. DOI：
10.1007/s00464-020-07592-7
|
| 14 |
Fujitani K, Yang HK, Mizusawa J, et al. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial [J]. The Lancet Oncology，2016, 17(3):309-318.
|
| 15 |
Ma F, Li Y, Li W, et al. Metastasectomy improves the survival of gastric cancer patients with krukenberg tumors: a retrospective analysis of 182 patients [J]. Cancer management and research，2019, 11:10573-10580. DOI：
10.2147/CMAR.S227684.
|
| 16 |
Al-Batran SE, Homann N, Pauligk C, et al. Effect of neoadjuvant chemotherapy followed by surgical resection on survival in patients with limited metastatic gastric or gastroesophageal junction cancer: the AIO-FLOT3 trial [J]. JAMA oncology，2017, 3(9):1237-1244.
|
| 17 |
Al-Batran SE, Goetze TO, Mueller DW, et al. The renaissance (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase Ⅲ trial of the German AIO/CAO-V/CAOGI [J]. BMC cancer，2017, 17(1):893-893.
|
| 18 |
Li Z, Shan F, Ying X, et al. Assessment of laparoscopic distal gastrectomy after neoadjuvant chemotherapy for locally advanced gastric cancer: a randomized clinical trial [J]. JAMA surgery, 2019，154(12) :1093-1101.
|
| 19 |
Yoshikawa T, Fukunaga T, Taguri M, et al. Laparoscopic or open distal gastrectomy after neoadjuvant chemotherapy for operable gastric cancer, a randomized phase ii trial (LANDSCOPE trial) [J]. Japanese journal of clinical oncology, 2012, 42(7):654-657.
|
| 20 |
Tsutsumi S, Oki E, Ida S, et al. Laparoscopic gastrectomy for gastric cancer with peritoneal dissemination after induction chemotherapy[J]. Case Reports in Gastroenterology，2013, 7(3):516-521.
|
| 21 |
Glehen O, Gilly FN, Arvieux C, et al. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy [J]. Annals of surgical oncology，2010, 17(9):2370-2377.
|
| 22 |
Newhook TE, Agnes A, Blum M, et al. Laparoscopic hyperthermic intraperitoneal chemotherapy is safe for patients with peritoneal metastases from gastric cancer and may lead to gastrectomy [J]. Annals of surgical oncology，2019, 26(5):1394-1400.
|
| 23 |
Beeharry MK, Ni ZT, Yang ZY, et al.Study protocol of a multicenter phase Ⅲ randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon Ⅱ trial [J]. BMC cancer，2020, 20(1):224-224.
|
| 24 |
Topal B, Demey K, Topal H，et al. Cytoreductive surgery and hyperthermic intra-operative peritoneal chemotherapy with cisplatin for gastric peritoneal carcinomatosis monocentric phase-2 nonrandomized prospective clinical trial [J]. BMC cancer，2017, 17(1):771-771.
|
| 25 |
Koemans WJ, Kaaij RT, Boot H, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE Ⅱ) [J]. BMC cancer，2019, 19(1):420.
|
| 26 |
Glehen O, Passot G, Villeneuve L, et al. Gastrichip: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase Ⅲ study [J]. BMC cancer，2014, 14:183. DOI：
10.1186/1471-2407-14-183.
|
| 27 |
Ba MC, Long H, Zhang XL, et al. Laparoscopic hyperthermic intraperitoneal perfusion chemotherapy for patients with malignant ascites secondary to unresectable gastric cancer [J]. Surgical laparoscopy, endoscopy & percutaneous techniques，2020, 30(1):55-61.
|
| 28 |
Ramos RF, Scalon FM, Scalon MM, et al. Staging laparoscopy in gastric cancer to detect peritoneal metastases: a systematic review and meta-analysis [J]. European journal of surgical oncology，2016, 42(9):1315-1321.
|
| 29 |
Liu K, Chen XZ, Zhang WH, et al. "Four-step procedure" of laparoscopic exploration for gastric cancer in west china hospital: a retrospective observational analysis from a high-volume institution in china [J]. Surgical endoscopy，2019, 33(5):1674-1682.
|
| 30 |
Yasufuku I, Nunobe S, Ida S, et al. Conversion therapy for peritoneal lavage cytology-positive type 4 and large type 3 gastric cancer patients selected as candidates for R0 resection by diagnostic staging laparoscopy [J]. Gastric cancer，2020, 23(2):319-327.
|
| 31 |
Kaminishi M, Yamaguchi H, Shimizu N, et al. Stomach-partitioning gastrojejunostomy for unresectable gastric carcinoma [J]. Archives of surgery，1997, 132(2):184-187.
|